AR054015A1 - Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad - Google Patents

Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad

Info

Publication number
AR054015A1
AR054015A1 ARP060100884A ARP060100884A AR054015A1 AR 054015 A1 AR054015 A1 AR 054015A1 AR P060100884 A ARP060100884 A AR P060100884A AR P060100884 A ARP060100884 A AR P060100884A AR 054015 A1 AR054015 A1 AR 054015A1
Authority
AR
Argentina
Prior art keywords
peritoneal dialysis
carnitine
solutions
peritoneum
solution
Prior art date
Application number
ARP060100884A
Other languages
English (en)
Inventor
Arduino Arduini
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of AR054015A1 publication Critical patent/AR054015A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)

Abstract

Se divulga el efecto protector sobre el peritoneo de la L-carnitina y sus derivados de alcanoílo inferior, tanto en la forma de sales internas o farmacéuticamente aceptables. Las concentraciones de carnitina comprendidas entre alrededor del 0,02 y el 0,5% p/v son adecuadas para preparar una solucion para la diálisis peritoneal más biocompatible que protege al peritoneo contra los efectos toxicos causados por el uso continuo de soluciones para diálisis peritoneal, en particular aquellas que contienen glucosa como agente osmotico. Una forma de realizacion particularmente preferida es una solucion para diálisis peritoneal que contiene carnitina, glucosa y xilitol.
ARP060100884A 2005-03-10 2006-03-09 Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad AR054015A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2005000130 2005-03-10

Publications (1)

Publication Number Publication Date
AR054015A1 true AR054015A1 (es) 2007-05-30

Family

ID=35159907

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060100884A AR054015A1 (es) 2005-03-10 2006-03-09 Soluciones para dialisis peritoneal que tienen mayor biocompatibilidad

Country Status (19)

Country Link
US (1) US20080138443A1 (es)
EP (1) EP1858504B1 (es)
JP (2) JP4717110B2 (es)
KR (1) KR101324920B1 (es)
AR (1) AR054015A1 (es)
AT (1) ATE539742T1 (es)
CA (1) CA2599252C (es)
CY (1) CY1112794T1 (es)
DK (1) DK1858504T3 (es)
ES (1) ES2380168T3 (es)
HR (1) HRP20120177T1 (es)
ME (1) ME02948B (es)
MX (1) MX2007010814A (es)
PL (1) PL1858504T3 (es)
PT (1) PT1858504E (es)
RS (1) RS52237B (es)
SI (1) SI1858504T1 (es)
TW (1) TWI388318B (es)
WO (1) WO2006094900A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2365429B1 (es) * 2010-03-05 2012-09-06 Universidad De Castilla De La Mancha Solucion para dialisis peritoneal
ES2750642A1 (es) * 2018-09-26 2020-03-26 Univ Vigo Composición farmacéutica que comprende proteína amiloide P de suero para tratar la insuficiencia renal aguda o crónica
EP3912656A1 (en) 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
JPH08131542A (ja) * 1994-11-11 1996-05-28 Baxter Kk 腹膜透析液調製用溶液セット
CA2155910C (en) 1995-08-11 1999-12-14 George Wu Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis
GB9714218D0 (en) * 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
JP2001513370A (ja) * 1997-08-07 2001-09-04 グプタ，アジャイ 水溶性ビタミン及び栄養素を含む透析溶液
DE19748290B8 (de) 1997-10-31 2009-09-03 Fresenius Medical Care Deutschland Gmbh Lösung für die Peritonealdialyse
DK1220670T3 (da) * 1999-10-11 2006-12-18 Sigma Tau Ind Farmaceuti Anvendelse af L-carnitin og dets alkanoylderivater som osmotiske stoffer i oplösninger til medicinsk anvendelse
JP2002282354A (ja) 2001-03-27 2002-10-02 Jms Co Ltd 腹膜透析液
GB0108359D0 (en) * 2001-04-03 2001-05-23 Allied Therapeutics Ltd Peritoneal dialysis fluid
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
FR2840612B1 (fr) * 2002-06-06 2005-05-06 Roquette Freres Polymeres solubles de glucose hautement branches et leur procede d'obtention
JP2004016615A (ja) * 2002-06-19 2004-01-22 Fuso Pharmaceutical Industries Ltd 晶質浸透圧剤及び膠質浸透圧剤を含有する腹膜透析液
US20060046975A1 (en) 2002-12-10 2006-03-02 Ola Carlsson Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液

Also Published As

Publication number Publication date
ATE539742T1 (de) 2012-01-15
RS52237B (en) 2012-10-31
CA2599252A1 (en) 2006-09-14
WO2006094900A1 (en) 2006-09-14
JP4717110B2 (ja) 2011-07-06
ME02948B (me) 2012-10-31
KR20070116630A (ko) 2007-12-10
PL1858504T3 (pl) 2012-05-31
KR101324920B1 (ko) 2013-11-01
TW200714279A (en) 2007-04-16
CA2599252C (en) 2013-07-30
JP2010207630A (ja) 2010-09-24
EP1858504A1 (en) 2007-11-28
PT1858504E (pt) 2012-04-10
CY1112794T1 (el) 2016-02-10
ES2380168T3 (es) 2012-05-09
DK1858504T3 (da) 2012-04-30
SI1858504T1 (sl) 2012-04-30
TWI388318B (zh) 2013-03-11
HRP20120177T1 (hr) 2012-03-31
JP5366894B2 (ja) 2013-12-11
EP1858504B1 (en) 2012-01-04
US20080138443A1 (en) 2008-06-12
JP2008532601A (ja) 2008-08-21
MX2007010814A (es) 2007-11-07

Similar Documents

Publication Publication Date Title
CO6290622A2 (es) Composiciones de activo antitranspirante con un cromatograma sec que presenta una elevada intensidad de pico 4 sec para reducir la transpiración
ES2620442T3 (es) Uso de derivados de tetraquis(N-alquilpiridinio)-porfirina para la destrucción de microbios o la prevención de su crecimiento
AR062046A1 (es) Soluciones oftalmicas
ES2557303T3 (es) Agente terapéutico para la estenosis del canal espinal
AR054227A1 (es) Composicion de principios activos
UY28285A1 (es) Péliculas consumibles por vía oral que se disuelven rápidamente, que contienen un edulcorante
AR052428A1 (es) Composicion contra las caries para el cuidado oral con xilitol
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática
ES2537539T3 (es) Composición oftálmica
CL2009000625A1 (es) Composicion farmaceutica que comprende a)un primer poliol seleccionado de manitol, sorbitol o una combinacion de ambos, b)segundo poliol seleccionado de propilenglicol, glicerina o una combinacion de ambas, c)complejo de borato en un 0,5% p/v de la composicion total, d)preservante, e)agua; util para el tratamiento del ojo.
AR081983A1 (es) Articulo de dosis unitaria soluble que comprende un polimero cationico
ECSP055702A (es) Administración de sales de anfetamina de liberación sostenida
BR112015025961A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
AR044964A1 (es) Formulaciones para microproyecciones recubiertas que contienen contra-iones no volatiles
PA8601801A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
CL2011000170A1 (es) Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa.
CL2020000293A1 (es) Gel que comprende clorhexidina.
GT200900284A (es) Dosis intravenosa y oral de un inhibidor p2y12 de accion directa y reversible.-
AR061887A1 (es) Una composicion de vacuna contra el dengue
AR071183A1 (es) Composicion oral que comprende un componente activo y un componente formador de pelicula adhesiva, metodo
AR074841A1 (es) Composicion que comprende aceite de canamo para tratar enfermedades topicas, especialmente el sindrome mano-pie
AR052855A1 (es) Composiciones para el cuidado bucal que contienen un extrato de eucalyptus
AR068081A1 (es) Metodo mejorado para el tratamiento de productos agricolas, alimenticios y piensos con un compuestos antifungico de polieno
AR039164A1 (es) Sales de venlafaxina de baja solubilidad en agua
CO5251448A1 (es) Soluciones que contienen epinastina

Legal Events

Date Code Title Description
FB Suspension of granting procedure